SCHEMBL5940570

SCHEMBL5940570

c1cnnc(-c2ccsc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 4/20 0.48
▸ CYP2B6 P20813 3/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NPC1 O15118 1/20 0.46
▸ CYP2E1 P05181 2/20 0.43
▸ PPARA Q07869 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ CYP17A1 P05093 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ HRH4 Q9H3N8 1/20 0.36
▸ TOP1 P11387 1/20 0.36
▸ FYN P06241 2/20 0.36
▸ CHRNA7 P36544 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1456246 0.74 MAPT (0.46) CYP3A4CYP2C9CYP2C19NPC1HDAC4
SCHEMBL597347 0.73 KDM4E (0.52) CYP2A6CYP2B6CYP3A4CYP2C9CYP2C19
SCHEMBL29723603 0.73 KDM4E (0.52) CYP2A6CYP2B6CYP3A4CYP2C9CYP2C19
SCHEMBL10338184 0.72 — —
SCHEMBL30792004 0.72 GOT1 (0.46) NPC1CYP11B2HDAC4DHODH
SCHEMBL1456807 0.72 GOT1 (0.46) NPC1CYP11B2HDAC4DHODH
SCHEMBL29442588 0.72 GOT1 (0.46) NPC1CYP11B2HDAC4DHODH
SCHEMBL121970 0.72 RAB9A (0.50) CYP2A6NPC1HDAC4DHODH
SCHEMBL29959678 0.72 RAB9A (0.50) CYP2A6NPC1HDAC4DHODH
SCHEMBL29779555 0.71 WNT3A (0.51) CYP2A6HDAC4DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207472-A Inhibitors of AKT kinase 卑尔根生物股份公司 2017-09-26 — — CN disclosed
US-20060235021-A1 Phenylpyridazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. (GB) 2006-10-19 — — US disclosed
EP-0165753-B1 HERBICIDAL THIOPHENESULFONAMIDES AND PYRIDINESULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-12-11 — — EP disclosed
US-4723988-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-02-09 — — US disclosed
US-4684393-A PLATN GROWTH REGULATORS E. I. DUPONT DE NEMOURS AND COMPANY (US) 1987-08-04 — — US disclosed
EP-0165753-A2 Herbicidal thiophenesulfonamides and pyridinesulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-12-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235021-A1 Phenylpyridazine derivatives as ligands for gaba receptors GABRA5, GABRA2, GABRA3 CYP2A6 385/4885CYP2B6 387/4885CYP3A4 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback